Fig. 6: Overexpression of DEPDC1A attenuated the effects on bladder cancer cells by ALPK2 knockdown.
From: ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A

EJ and T24 cell models with mere DEPDC1A overexpression or simultaneous DEPDC1A overexpression and ALPK2 knockdown were subjected to the detection of cell proliferation by Celigo cell counting assay (A, D), cell migration by wound-healing assay (B, E) and cell migration by Transwell assay (C, F). Data were shown as mean ± SD. ***P < 0.001.